Concepedia

D. Scott McMeekin

DS

74

Publications

6.9K

Citations

41

H-Index

1995

Active since

Affiliations

University of Oklahoma Health Sciences Center(Current)

University of Oklahoma

Gynecologic Oncology Group

Oklahoma City University

Roswell Park Comprehensive Cancer Center

D. Scott McMeekin is an author at University of Oklahoma Health Sciences Center specializing in oncology, obstetrics, and medicine.

Top concepts

Publications per year

1995–2019

74

Publications

74

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Richard G. Moore, D. Scott McMeekin, Amy Brown et al. · Gynecologic Oncology · 2008 · 852 citations

, , +8

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

Bradley J. Monk, Michael W. Sill, D. Scott McMeekin et al. · Journal of Clinical Oncology · 2009 · 681 citations · Full text

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Harry J. Long, Brian N. Bundy, Edward C. Grendys et al. · Journal of Clinical Oncology · 2005 · 554 citations

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer

Marcus E. Randall, Virginia L. Filiaci, D. Scott McMeekin et al. · Journal of Clinical Oncology · 2019 · 315 citations · Full text

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

Carol Aghajanian, Michael W. Sill, Kathleen M. Darcy et al. · Journal of Clinical Oncology · 2011 · 312 citations · Full text

Rows per page

1–5 of 74